ADOCIA confirms its eligibility for the PEA-PME
6:00 p.m. CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and other metabolic diseases, confirms that it is eligible for the PEA tax scheme – SME whose implementing decree was published in the Official Journal on March 4, 2014 (decree no. 2014-283) and entered into force on March 6, 2014.
To be eligible for the PEA – PME, the securities must have been issued by a company whose market capitalization is less than one billion euros, which employs less than 5,000 employees, and which achieves an annual turnover not exceeding not 1.5 billion euros or has a balance sheet total of less than 2 billion euros.
Adocia fulfills all the criteria.